- Home
- AEHL vs APVO Comparison
AEHL vs APVO Comparison
Compare AEHL & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- APVO
- Stock Information
- Founded
- AEHL 1993
- APVO 2016
- Country
- AEHL United States
- APVO United States
- Employees
- AEHL N/A
- APVO N/A
- Industry
- AEHL Building Materials
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- AEHL Industrials
- APVO Health Care
- Exchange
- AEHL Nasdaq
- APVO Nasdaq
- Market Cap
- AEHL 5.6M
- APVO 6.5M
- IPO Year
- AEHL 2007
- APVO N/A
- Fundamental
- Price
- AEHL $0.18
- APVO $4.46
- Analyst Decision
- AEHL
- APVO Strong Buy
- Analyst Count
- AEHL 0
- APVO 1
- Target Price
- AEHL N/A
- APVO $296.00
- AVG Volume (30 Days)
- AEHL 4.2M
- APVO 90.6K
- Earning Date
- AEHL 09-30-2024
- APVO 03-04-2025
- Dividend Yield
- AEHL N/A
- APVO N/A
- EPS Growth
- AEHL N/A
- APVO N/A
- EPS
- AEHL N/A
- APVO N/A
- Revenue
- AEHL $69,082,235.00
- APVO N/A
- Revenue This Year
- AEHL N/A
- APVO N/A
- Revenue Next Year
- AEHL N/A
- APVO N/A
- P/E Ratio
- AEHL N/A
- APVO N/A
- Revenue Growth
- AEHL 1.87
- APVO N/A
- 52 Week Low
- AEHL $0.15
- APVO $3.65
- 52 Week High
- AEHL $6.41
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- AEHL 40.94
- APVO 38.21
- Support Level
- AEHL $0.15
- APVO $4.32
- Resistance Level
- AEHL $0.29
- APVO $4.79
- Average True Range (ATR)
- AEHL 0.03
- APVO 0.45
- MACD
- AEHL 0.00
- APVO 0.15
- Stochastic Oscillator
- AEHL 18.79
- APVO 19.53
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd is a manufacturer of ceramic tiles in China. Its ceramic tiles are used for exterior siding, interior flooring, and design in residential and commercial buildings. The company's products are Porcelain, Glazed, Glazed porcelain, Rustic, and polished glazed tiles. The Company operates in the manufacturing and sale of medium to high-end ceramic tiles and providing business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.